FDA sends Dollar Tree warning letter for selling 'potentially unsafe drugs' from Chinese suppliers

Dollar Tree is under fire for stocking “potentially unsafe drugs” and cosmetics.

“Americans expect and deserve drugs that are safe, effective and that meet our standards for quality,” Donald D. Ashley, director of the Office of Compliance in the FDA’s Center for Drug Evaluation and Research, said in the release.

“In this case, Dollar Tree has the ultimate responsibility to ensure that it does not sell potentially unsafe drugs and other FDA-regulated products to Americans.”

According to the FDA, Dollar Tree received prior warning letters between 2016 and 2019, including notification of letters sent to the manufacturers who were placed on “import alert, which are used to prevent potentially violative products from being imported into the U.S. market.”

Randy Guiler, Dollar Tree’s vice president of investor relations, said in a statement to CNBC that the items referenced by the FDA were “topical, not ingestible products.”

“We are committed to our customers’ safety and have very robust and rigorous testing programs in place to ensure our third-party manufacturers’ products are safe,” Guiler said in the statement to CNBC, noting the company was cooperating and plans to meet with FDA in the near future.

Powered by Blogger.